Prevalence of Hypertension and Its Associated Factors Among Adults Living with HIV on Antiretroviral Treatment in Selected Public Hospitals in Addis Ababa, Ethiopia

References

• Dagnaw WW, Yadeta D, Feleke Y, Kebede T. Ethiopian national guideline on major NCDs 2016 guidelines on clinical and programmatic management of major non communicable diseases; 2016.
   Google Scholar
• Risk NCD, Collaboration F. Articles worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants; 2021;398.
   Google Scholar
• World Health Organization. Non-communicable diseases; 2021. Available from: https://who.int/news-room/factsheet/detail/noncommunicable-diseases. Accessed March 9, 2024.
   Google Scholar
• Sheet F. FACT SHEET 2021 Global HIV statistics; 2021; 1–6.
   Google Scholar
• Frank TD, Carter A, Jahagirdar D, et al. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980 – 2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the global burden of diseases, injuries, and risk factors study 2017. The Lancet HIV. 2019;6:831–859.
   PubMed Web of Science ®Google Scholar
• Feinstein MJ, Hsue PY, Bloomfield GS, et al. HHS Public Access; 2021.
   Google Scholar
• Roth GA, Abate KH, Abay SM Global Health Metrics Global, regional, and national age-sex-specific mortality and life expectancy, 1950 – 2017: a systematic analysis for the Global Burden of Disease Study 2017. 2018:1980–2017.
   Google Scholar
• Shah ASV, Stelzle D, Lee KK, et al. Europe PMC funders group global burden of atherosclerotic cardiovascular disease in people living with the human immunodeficiency virus: a systematic review and meta-analysis. Circulation. 2019;138(11):1100–1112.
   Web of Science ®Google Scholar
• Fahme SA, Bloomfield GS, Peck R Hypertension in HIV-Infected Adults: novel Pathophysiologic Mechanisms; 2018:44–55.
   Google Scholar
• Peck RN, Shedafa R, Kalluvya S, et al. Hypertension, kidney disease, HIV and antiretroviral therapy among Tanzanian adults: a cross-sectional study. BMC Med. 2014;12(125):1–11. doi:10.1186/s12916-014-0125-2
   Google Scholar
• Nguyen KA, Peer N, Mills EJ, et al. Burden, determinants, and pharmacological management of hypertension in HIVpositive patients and populations: a systematic narrative review. AIDS Rev. 2015;17(2):83–95. PMID: 26035166.
   PubMed Web of Science ®Google Scholar
• Lukas K, Markos E, Belayneh F, Habte A, Torpey K. The magnitude of hypertension and associated factors among clients on highly active antiretroviral treatment in Southern Ethiopia, 2020:A hospital-based cross-sectional study. PLoS One. 2021;16(10):e0258576. doi:10.1371/journal.pone.0258576
   PubMed Web of Science ®Google Scholar
• Id AG. Hypertension among people living with human immunodeficiency virus receiving care at referral hospitals of Northwest Ethiopia. PLoS One. 2020:1–13. doi:10.1371/journal.pone.0238114
   Web of Science ®Google Scholar
• Sewale Y, Afenigus AD, Haile D, Shiferaw WS. Magnitude of hypertension and associated factors among human immunodeficiency virus positive adults receiving anti-retroviral therapy at debre markos referral hospital, Northwest, Ethiopia. HIV AIDS. 2020;12:629–637. PMID: 33116925; PMCID: PMC7588266. doi:10.2147/HIV.S280630
   Google Scholar
• Fiseha T, Belete AG, Dereje H, Dires A Hypertension in HIV-infected patients receiving antiretroviral therapy in Northeast Ethiopia; 2019.
   Google Scholar
• Jamieson L, Njc I, Fox MP, et al. And control of hypertension among HIV- positive adults on antiretroviral treatment in public sector treatment programs in South Africa; 2018:1–19.
   Google Scholar
• Nduka CU, Stranges S, Sarki AM, Kimani PK, Uthman OA. Evidence of increased blood pressure and hypertension risk among people living with HIV on antiretroviral therapy: a systematic review with meta-analysis. Journal of Human Hypertension. 2016;30(6):355–362. doi:10.1038/jhh.2015.97
   PubMed Web of Science ®Google Scholar
• Davis K, Perez-Guzman P, Hoyer A, et al. Association between HIV infection and hypertension: a global systematic review and meta-analysis of cross-sectional studies. BMC Med. 2021;19(105):1–6. doi:10.1186/s12916-021-01978-7
   PubMedGoogle Scholar
• Getahun Z, Azage M, Abuhay T. Comorbidity of HIV, hypertension, and diabetes and associated factors among people receiving antiretroviral therapy in Bahir Dar city. Ethiopia. 2020;10:1–12.
   Google Scholar
• Kebede B, Ayele G, Haftu D, Gebremichael G The prevalence and associated factors of hypertension among adults in Southern Ethiopia; 2020.
   Google Scholar
• Stepwise TWHO. The WHO STEPwise approach to chronic disease risk factor surveillance (STEPS); 2015.
   Google Scholar
• Ababa A Guidelines on clinical and programmatic management of major non communicable diseases; 2016.
   Google Scholar
• Debiso AT. Incidence and predictors of systemic hypertension among cohort of HIV / aids infected patients in health facilities of South Ethiopia; 2020:47–63. Available from: 10.4236/aid.2020.102005. Accessed March 9, 2024.
   Google Scholar
• Federal Ministry of Health. National comprehensive HIV prevention, care and treatment training for health care providers. Participant manual; 2018:1–123.
   Google Scholar
• Division of HIV/AIDS prevention, national center for HIV/AIDS, viral hepatitis, STD, and TB prevention, centers for disease control and prevention. Available from: https://www.cdc.gov/hiv/basics/livingwithhiv/opportunisticinfections.html. Accessed May 20, 2021.
   Google Scholar
• Costa AN, Val F, Macedo ÁE, Cubas-vega N, Vinicius M, Lacerda G. Major article increased prevalence of hypertension among people living with HIV: where to begin ?; 2020:1–6.
   Google Scholar
• Olaiya O, Weiser J, Zhou W, Patel P, Bradley H. Hypertension among persons living with HIV in medical care in the United States — medical monitoring; 2014:1–5.
   Google Scholar
• Lubega G, Mayanja B, Lutaakome J, et al. Prevalence and factors associated with hypertension among people living with HIV / AIDS on antiretroviral therapy in Uganda; 2021.
   Google Scholar
• Njelekela M, Muhihi A, Aveika A, et al. Prevalence of hypertension and its associated risk factors among 34, 111 HAART Na \ ve HIV-infected adults in dar es Salaam, Tanzania; 2016.
   Google Scholar
• Africa W, Seydi M, Doye IN, et al. Increasing prevalence of hypertension among HIV-positive and negative adults in Senegal; 2018;1–14.
   Google Scholar
• Chiwandire N, Zungu N, Mabaso M, Chasela C. Trends, prevalence and factors associated with hypertension and diabetes among South African adults living with HIV, 2005 – 2017; 2021;1–14.
   Google Scholar
• Sharma JR, Mabhida SE, Myers B, et al. Prevalence of hypertension and its associated risk factors in a rural black population of Mthatha town, South Africa; 2021.
   Google Scholar
• Mbuthia GW, Magutah K, Mcgarvey ST. HIV Patients. Int J Hyperten. 2021;2021:8. doi:10.1155/2021/5544916
   Google Scholar
• Ephraim RKD, Sakyi SA, Fondjo LA, Afrifa J, Agyeman P, Darko P. Determinants of isolated systolic hypertension among HIV / AIDS on highly active antiretroviral therapy: a cross sectional study in the GA South metropolis; 2018:360–364.
   Google Scholar
• Arruda Junior ER, Lacerda HR, Moura LC, et al. Risk factors related to hypertension among patients in a cohort living with HIV/AIDS. Braz J Infect Dis. 2010;14(3):281–287. PMID: 20835513. doi:10.1590/s1413-86702010000300014
   PubMed Web of Science ®Google Scholar
• Dzudie A, Hoover D, Kim H, et al. Hypertension among people living with HIV / AIDS in Cameroon: a cross-sectional analysis from central Africa international epidemiology databases to evaluate AIDS. PLOS ONE. 2021:1–17. doi:10.1371/journal.pone.0253742
   Web of Science ®Google Scholar
• van Zoest RA. Ageing with HIV: from pathogenesis to policy; 2019.
   Google Scholar